Direct interaction of c-Myc with Smad2 and Smad3 to inhibit TGF-β-mediated induction of the CDK inhibitor p15Ink4B

被引：183

作者：

Feng, XH ^{[1
]}

Liang, YY

Liang, M

Zhai, WG

Lin, X

机构：

[1] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA

[2] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA

[3] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA

来源：

MOLECULAR CELL | 2002年 / 9卷 / 01期

关键词：

D O I：

10.1016/S1097-2765(01)00430-0

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The c-Myc oncogene has been implicated in the genesis of diverse human tumors. Ectopic expression of the c-Myc gene in cultured epithelial cells causes resistance to the antiproliferative effects of TGF-beta. However, little is known about the precise mechanisms of c-Myc-mediated TGF-beta resistance. In this study, we reveal that c-Myc physically interacts with Smad2 and Smad3, two specific signal transducers involved in TGF-beta signaling. Through its direct interaction with Smads, c-Myc binds to the Sp1-Smad complex on the promoter of the p15(Ink4B) gene, thereby inhibiting the TGF-beta-induced transcriptional activity of Sp1 and Smad/Sp1-dependent transcription of the p15(Ink4B) gene. These results suggest that oncogenic c-Myc promotes cell growth and cancer development partly by inhibiting the growth inhibitory functions of Smads.

引用

页码：133 / 143

页数：11

共 50 条

[1] A combination treatment of c-myc antisense DNA with all-trans-retinoic acid inhibits cell proliferation by downregulating c-myc expression in small cell lung cancer
Akie, K
Dosaka-Akita, H
Murakami, A
Kawakami, Y
[J]. ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 2000, 10 (04): : 243 - 249
[2] OVEREXPRESSION OF THE C-MYC ONCOPROTEIN BLOCKS THE GROWTH-INHIBITORY RESPONSE BUT IS REQUIRED FOR THE MITOGENIC EFFECTS OF TRANSFORMING GROWTH-FACTOR-BETA-1
ALEXANDROW, MG
KAWABATA, M
AAKRE, M
MOSES, HL
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (08) : 3239 - 3243
[3] Barrett MT, 1996, CANCER RES, V56, P4351
[4] Mechanisms of disease:: Role of transforming growth factor β in human disease.
Blobe, GC
Schiemann, WP
Lodish, HF
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (18) : 1350 - 1358
[5] Cooperation of E2F-p130 and Sp1-pRb complexes in repression of the Chinese hamster dhfr gene
Chang, YC
Illenye, S
Heintz, NH
[J]. MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (04) : 1121 - 1131
[6] Defective repression of c-myc in breast cancer cells:: A loss at the core of the transforming growth factor β growth arrest program
Chen, CR
Kang, YB
Massagué, J
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (03) : 992 - 999
[7] Molecular therapy with recombinant antisense c-myc adenovirus for human gastric carcinoma cells in vitro and in vivo
Chen, JP
Lin, C
Xu, CP
Zhang, XY
Fu, M
Deng, YP
Wei, Y
Wu, M
[J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2001, 16 (01) : 22 - 28
[8] Myc-mediated transformation: the repression connection
Claassen, GF
Hann, SR
[J]. ONCOGENE, 1999, 18 (19) : 2925 - 2933
[9] A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor β-induced cell-cycle arrest
Claassen, GF
Hann, SR
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (17) : 9498 - 9503
[10] The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation
Cole, MD
McMahon, SB
[J]. ONCOGENE, 1999, 18 (19) : 2916 - 2924

← 1 2 3 4 5 →